Our previous study revealed that the MyD88 dimerization inhibitor, ST2825, can suppress systemic inflammation in RA and suggested that it may also likely modulate gene expression in the RA synovium [30]. This evidence concerns the gene MYD88 and rheumatoid arthritis.